查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496032

快速門診市場：2024-2029 年預測

Retail Clinics Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計快速門診市場在預測期內將以 4.02% 的複合年成長率成長，從 2022 年的 46.46 億美元增至 2029 年的 61.21 億美元。

快速門診市場不僅在市場方面而且在提供的服務範圍方面都在經歷顯著成長。這些零售環境在多種慢性疾病的診斷和護理中發揮重要作用，包括糖尿病、氣喘、過敏、關節炎、腎臟疾病和高血壓。

非傳染性疾病 (NCD) 每年造成 4,100 萬人死亡，佔全球整體死亡人數的 74%。其中，心血管疾病最為常見，每年將導致 1,790 萬人死亡，其次是癌症（930 萬人）、慢性呼吸道疾病（410 萬人）和糖尿病（2022 年將導致 200 萬人死亡）。這些數字顯示了情勢的活力以及衛生環境做出相應改變的必要性。

到 2022 年，僅美國就有 85% 的快速門診將歸 CVS、克羅格、沃爾格林和沃爾瑪等大型零售連鎖店所有，這說明了系統性變化。為了促進護理的連續性，將快速門診管理的疾病的臨床通訊協定整合到電子健康記錄系統中非常重要。此外，應建立既定流程，以方便轉診至衛生系統內的基層醫療醫師。

此外，老年人口的成長以及遠端醫療和診斷工具的進步正在使市場蓬勃發展。

老年人口的增加預計將推動市場成長。

近年來，大多數國家經歷了重大的人口變化，面臨多種健康要求和挑戰。例如，在日本，老年人口佔總人口的比例逐漸上升，2020年將達到28.559%，2021年將達到28.855%，2022年將達到29.001%。

隨著人口老化，慢性病也會增加。在低收入和中等收入國家 (LMIC)，75% 的非傳染性疾病 (NCD) 死亡發生在 60 歲及以上的成年人中，這增加了老年人尋求診所服務的需求。

此外，不斷成長的老年人口往往需要頻繁就診，快速門診可以透過提供方便且具成本效益的護理來滿足這一需求。

經合組織成員國老年人口佔人口比例不斷上升，2021年將達17.694%，2022年將達17.964%。根據世界銀行估計，到2050年，65歲或以上的人口將達到15億人。行業趨勢擴大使像 MinuteClinic 這樣的快速門診變得更加適合老年人，並增強其有效服務老年人的能力。

照護現場診斷在零售診所的應用預計將擴大

隨著人口老化和照護端 (POC) 診斷提供更快的結果，對這些測試的需求預計會增加。此外，行動診斷設備日益增加的多功能性是推動中等收入國家就地檢驗成長的關鍵因素。此外，推動該市場擴張的一個重要趨勢是公共和私人組織資金的增加。例如，2022年9月，Unitide承諾投資3,000萬美元加速尖端診斷技術的採用，這將改善篩檢工作，減少醫療系統較低階使用檢測的可能性將會增加。

此外，糖尿病的盛行率在世界各地不斷增加，對一般人群構成嚴重的健康風險，因為它是許多其他健康併發症的主要原因。世界衛生組織 (WHO) 估計，全球有 4.22 億人患有糖尿病，該疾病每年直接導致 150 萬人死亡。與高所得國家相比，低收入和中等收入國家的糖尿病盛行率正在迅速增加。很明顯，糖尿病的主要原因是可改變的代謝、環境和行為因素。這增加了對就地檢驗、早期篩檢、足夠的認知和醫療干預的需求。

此外，旨在在患者會診時快速提供結果、最大程度地減少患者就診次數並改善血糖控制的照護現場對於糖尿病管理是有益的。此外，旨在改善糖尿病患者的臨床結果和生活品質的就地檢驗（POC​​T）在基層醫療中普及。

該市場的另一個特點是領先公司採取高水準的策略舉措，包括聯盟、合作夥伴併購(M&A)。例如，Werfen 於 2023 年 3 月收購了 Immucor, Inc.，在專業診斷市場中獲得了主要立足點。收購價格為20億美元。

此外，西門子醫療有限公司與 Unilab 於 2023 年 5 月簽署了價值超過 2 億美元的合作夥伴關係。作為協議的一部分，Unilab 購買了 400 台測試分析儀並升級了其患者照護基礎設施。

此外，印度第一家照護現場公司 Lumiradex Healthcare Private Limited 宣布將於 2022 年 11 月推出超靈敏 C 反應蛋白 (CRP)照護現場抗原測試。在各種臨床環境中，照護現場CRP 檢測可用於減少抗生素過度處方，導致抗生素抗藥性。 CRP 測試可在重量僅超過 1 公斤的輕型 Lumiradex 平台上使用小指刺血樣本在 4 分鐘內完成。

預計北美地區市場將會成長。

由於醫療保健系統的改善、感染疾病患者數量的增加、人口老化以及易於獲得的高品質診斷測試，美國市場正在不斷擴大。此外，美國老年人的數量正在迅速增加。例如，根據美國健康排名（聯合健康基金會），美國65歲及以上人口比例將從2021年的16.8%增加到2022年的17.3%。

此外，隨著年齡的成長，患糖尿病和肥胖等各種疾病的風險急劇增加。這些情況也會顯著增加感染疾病的風險。老年人更容易罹患各種疾病，包括糖尿病、癌症、心臟病、肥胖、神經病變和肥胖。

此外，心臟病等慢性疾病是導致死亡的主要原因，對個人、家庭、醫療系統和醫療保健提供者帶來沉重負擔。根據美國疾病管制與預防中心的數據，到 2022 年，4.9% 的成年人將被診斷出患有心臟疾病。這表明，由於循環系統相關問題的治療藥物的供應不斷增加，市場在研究期間可能會成長。

此外，國際參與者進入市場預計將進一步推動該國快速門診的需求。例如，沃爾瑪將於 2022 年 4 月在佛羅裡達州開設五個配備醫生的新「沃爾瑪健康」中心中的第一家，為數萬名顧客提供低成本醫療保健服務。沃爾瑪健康 (Walmart Health) 正以位於柯林斯路 7075 號、毗鄰柯林斯路購物中心的傑克遜維爾商店為起點，進入佛羅裡達市場。在佛羅裡達州，傑克遜維爾、奧蘭多和坦帕地區計劃再開設至少四家商店。

此外，CVS Health 於 2022 年 5 月推出了 CVS Health 虛擬初級保健。這是一種全新的虛擬護理選項，可透過一個線上平台存取。透過這項服務，患者將能夠獲得 CVS Health 提供的臨床知識、資料和服務，從而創造一個更互聯、以患者為中心的醫療保健環境。

主要市場開拓：

  • 2022 年 10 月，印度領先的診斷實驗室之一 Genes2Me Pvt. Ltd. 宣布推出適用於 1-8 個檢體的 Rapi-Q-Point of Care RTPCR 解決方案。憑藉強大的軟體分析功能，這款經過 CE-IVD 認證的 POC 解決方案具有出色的性能、卓越的靈敏度和穩定的檢測。 Rapi-Q POC RTPCR 經過嚴格的品質檢查，並已獲得 ICMR核准。這種輕質、可攜式、緊湊的系統一次可以處理多達 8 個檢體。 Rapi-Q 可以識別多種疾病，包括傳染性結核病、HIV、HCV、HBV、熱帶熱病和呼吸道疾病。

主要參與者

  • 沃爾格林公司 (Walgreen Co.) 是快速門診市場的領導企業，以沃爾格林 (Walgreens) 品牌營運。該公司透過位於零售店內的診所提供便利的醫療保健服務。沃爾格林在美國擁有廣泛的業務，為常見疾病和預防保健提供便利的醫療保健解決方案。
  • 沃爾瑪公司利用其廣泛的零售店網路將自己定位為快速門診領域的重要競爭對手。在沃爾瑪健康旗下，該公司提供負擔得起的初級保健服務，包括健康檢查、篩檢和健康計劃。
  • Rite Aid 是一家知名藥局連鎖店，憑藉其 Ready Clinic 和 Now Clinic 品牌進入快速門診市場。這些診所提供各種醫療保健服務，包括免疫接種、身體檢查和虛擬諮詢，以滿足消費者不斷變化的需求。透過策略性地將診所設置在零售店內，Rite Aid 為尋求快速醫療照護的顧客提供了便利，同時增加了商店的人流。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章快速門診市場：依所有權分類

  • 介紹
  • 零售
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 醫院
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力

第6章快速門診市場：依應用分類

  • 介紹
  • 臨床化學和免疫檢測
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 疫苗接種
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 照護現場診斷
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力

第7章快速門診市場：依最終用戶分類

  • 介紹
  • 店鋪
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 購物中心
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 醫院
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場趨勢和機遇
    • 成長前景
    • 地域獲利能力

第8章快速門診市場：按地區

  • 介紹
  • 北美洲
    • 按所有權
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 按所有權
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 按所有權
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 按所有權
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 按所有權
    • 按用途
    • 按最終用戶
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Walgreen Co.,（Walgreens Boots Alliance, Inc.）
  • Walmart Inc.
  • Rite Aid Corp.
  • NextCare
  • Bellin Health Systems
  • Sutter Health
  • The Kroger Co.
  • CVS Health
  • MedExpress（Optum）
  • Concentra, Inc.
簡介目錄
Product Code: KSI061615711

The retail clinics market is anticipated to grow at a compound annual growth rate (CAGR) of 4.02% over the forecast period to reach US$6.121 billion by 2029, increasing from US$4.646 billion in 2022.

The retail clinics market is experiencing significant growth not just in the market but also in the scope of services delivered. Such retail settings play a significant role in the diagnosis and care of multiple chronic diseases, such as diabetes, asthma, allergies, arthritis, kidney disease, and hypertension.

Noncommunicable diseases (NCDs) cause the deaths of 41 million people annually, accounting for 74% of all global deaths. Among these, cardiovascular diseases account for most deaths, with 17.9 million people annually, followed by cancers at 9.3 million, chronic respiratory diseases accounts for 4.1 million deaths, and diabetes 2.0 million in 2022. These figures show the vitality of the situation and the corresponding need for the changes in health setup.

In 2022, 85% of retail clinics were owned by large retail chains like CVS, Kroger, Walgreens, and Walmart, 2022, in the US alone, showing that change in the system. To promote continuity of care, it is important to integrate clinical protocols for conditions managed at retail clinics into electronic health record systems. Additionally, established processes should be implemented to facilitate referrals to primary care physicians affiliated with the health system.

Further, the growing elderly population and advancements in telemedicine and diagnostic tools allow the market to flourish.

Growing geriatric population anticipated to propel market growth.

In recent years, the change in the demography of the country has been very significant in most countries, and they are facing multiple health requirements and challenges., such as For example, Japan where the proportion of Japan's elderly population, representing a percentage of the total population, witnessed a gradual increase, reaching 28.559% in 2020, 28.855% in 2021, and 29.001% in 2022., with urban areas hosting approximately 92% of the total population ., Hence, there is a heightened demand for senior care infrastructure.

As populations age, chronic diseases will also increase. The need for elderly individuals seeking clinic services has increased as in low- and middle-income countries (LMICs), 75 percent of deaths from noncommunicable diseases (NCDs) occur among adults over 60.

Further, the growing elderly population often requires frequent medical attention and retail clinics can cater to this demand by providing convenient and cost-effective care.

The Elderly population total percentage of the population was 17.694% in 2021 and increased to 17.964% in 2022 in OECD countries. As estimated by the World Bank, by 2050, 1.5 billion people will be 65 and older. A growing industry trend is the adaptation of retail clinics like MinuteClinic to be more age-friendly, enhancing their capabilities to effectively serve older adults.

The retail clinic's application in point of care diagnostics is projected to grow

The aging population and point-of-care (POC) diagnostics' ability to produce fast results are expected to drive up demand for these tests. Furthermore, the increasing versatility of mobile diagnostic devices is a primary factor propelling the growth of point-of-care testing in middle-income countries. Furthermore, a significant trend propelling the market expansion of this market is an increase in funding from public and private entities. For instance, in September 2022, Unitaid stated to invest US$30 million to hasten the adoption of cutting-edge diagnostic technologies, which would improve screening efforts and increase the availability of testing at lower levels of the healthcare system

Moreover, the prevalence of diabetes is increasing worldwide, and it poses serious health risks to the general public as it is a major cause of many other comorbid health consequences. The World Health Organization (WHO) estimates that 422 million people worldwide have diabetes and that the illness directly causes 1.5 million deaths per year Compared to high-income countries, the prevalence of diabetes has been rising faster in low- and middle-income nations. The primary causes of diabetes have been identified as modifiable metabolic, environmental, and behavioral factors. This has led to an increased demand for point-of-care testing, early screening, sufficient awareness, and health care intervention.

Further, point-of-care diagnostics, which aims to provide quick results during patient consultation to minimize the number of patient visits and improve glycemic control, is beneficial for managing diabetes. Furthermore, point-of-care testing (POCT), which is intended to enhance clinical outcomes and the quality of life for diabetics, is becoming increasingly popular in primary care.

High levels of strategic initiatives, including alliances, partnerships, and mergers and acquisitions (M&A) by dominant firms, are another market feature. For instance, Werfen purchased Immucor, Inc. in March 2023 to forge a significant foothold in the specialized diagnostics market. The transaction was worth two billion dollars.

Moreover, Siemens Healthcare GmbH and Unilabs entered into a partnership in May 2023 with a value of more than $200 million. As part of the agreement, Unilabs purchased 400 laboratory analyzers to upgrade the infrastructure for patient care.

Additionally, LumiraDx Healthcare Private Limited, the first point-of-care diagnostics company in India, has announced that its ultrasensitive C-Reactive Protein (CRP) point-of-care antigen test will debut in November 2022. In a variety of clinical contexts, the point-of-care CRP test can be employed to lessen the overprescription of antibiotics, which contributes to antibiotic resistance. The CRP test can be performed on the lightweight, slightly over a kilogram LumiraDx platform in four minutes using a small finger prick blood sample.

The market is projected to grow in the North American region.

The market in the United States is expanding as a result of an enhanced healthcare system, an increase in cases of infectious diseases, an aging population, and easily available, high-quality diagnostic tests. Furthermore, the number of elderly people in the US is rising quickly. For instance, according to America's Health Ranking (United Health Foundation), the percentage of the population aged 65 and older increased from 16.8% in 2021 to 17.3% in 2022 in the United States.

In addition, as people age, their risk of developing a number of diseases, including diabetes and obesity, rises dramatically. Infectious disease risk is also significantly increased by these circumstances. The elderly are susceptible to a wide range of diseases, such as diabetes, cancer, heart disease, obesity, neurological disorders, and obesity.

Furthermore, chronic illnesses like heart disease are a major cause of mortality that place a heavy burden on individuals, families, healthcare systems, and providers. As per the Centers for of Disease Control and Prevention, in 2022, 4.9% of adults had ever received a coronary heart disease diagnosis. This suggests that the market could experience growth during the studied period due to the rising utilization of therapeutics for issues related to cardiology.

In addition, expansion ventures by international players into the market are further expected to boost the retail clinics demand in the country. For instance, Walmart expanded its low-cost healthcare services to tens of thousands of its customers by opening the first of five new "Walmart Health" centers with doctor staff in Florida in April 2022. Walmart Health is entering the Florida market with these openings, starting with the new Jacksonville location at 7075 Collins Road, which is next to the Collins Road Supercenter. There will be at least four more Florida locations opening in the Jacksonville, Orlando, and Tampa regions.

Moreover, CVS Health introduced CVS Health Virtual Primary Care in May 2022. This is a brand-new virtual care option that can be accessed via one online platform. Through this offering, patients would have access to clinical knowledge, data, and services from CVS Health in a more coordinated, patient-centered healthcare environment

Key Market Developments:

  • October 2022, Genes2Me Pvt. Ltd., one of India's leading diagnostic laboratories, announced the introduction of its Rapi-Q- Point of Care RTPCR solution for 1-8 samples, which is simple to use and provides results in less than 45 minutes. Because of its strong software analysis function, this CE-IVD marked POC solution provides outstanding performance, excellent sensitivity, and stable detection. The Rapi-Q point of care RTPCR has been approved by the ICMR after undergoing stringent quality checks. This lightweight, portable, and compact system can process up to eight samples in a single run. Rapi-Q can identify a wide range of diseases, including infectious tuberculosis, HIV, HCV, and HBV, tropical fever, and respiratory disorders.

Key Players:

  • Walgreen Co. is a prominent player in the retail clinics market, operating under the Walgreens brand. It offers accessible healthcare services through its clinics located within its retail stores. With a widespread presence across the United States, Walgreens provides convenient healthcare solutions for common ailments and preventive care. Its integrated approach combining pharmacy services and healthcare clinics makes it a go-to destination for many consumers seeking convenient medical assistance.
  • Walmart Inc. has established itself as a significant contender in the retail clinics sector, leveraging its extensive network of retail outlets. Operating under the Walmart Health banner, the company provides a range of primary care services, including check-ups, screenings, and wellness programs, at affordable prices. By integrating healthcare services into its supercenters, Walmart aims to improve access to medical care for underserved communities while capitalizing on its existing customer base.
  • Rite Aid Corp. is a well-known pharmacy chain that has ventured into the retail clinics market with its RediClinic and NowClinic brands. These clinics offer a variety of healthcare services, including vaccinations, physical exams, and virtual consultations, to cater to the evolving needs of consumers. Rite Aid's strategic placement of clinics within its retail locations enhances convenience for customers seeking quick medical attention while also driving foot traffic to its stores.

Segmentation:

By Ownership

  • Retail
  • Hospital
  • Others

By Application

  • Clinical Chemistry and Immunoassay
  • Vaccination
  • Point Of Care Diagnostics
  • Others

By End-User

  • Store
  • Mall
  • Hospitals
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. RETAIL CLINICS MARKET BY OWNERSHIP

  • 5.1. Introduction
  • 5.2. Retail
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Hospital
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Others
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness

6. RETAIL CLINICS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Clinical Chemistry and Immunoassay
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Vaccination
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Point Of Care Diagnostics
    • 6.4.1. Market Trends and Opportunities
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Trends and Opportunities
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. RETAIL CLINICS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Store
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Mall
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Hospitals
    • 7.4.1. Market Trends and Opportunities
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness
  • 7.5. Others
    • 7.5.1. Market Trends and Opportunities
    • 7.5.2. Growth Prospects
    • 7.5.3. Geographic Lucrativeness

8. RETAIL CLINICS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Ownership
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
        • 8.2.4.1.1. Market Trends and Opportunities
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Trends and Opportunities
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Trends and Opportunities
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Ownership
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Trends and Opportunities
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Trends and Opportunities
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Trends and Opportunities
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Ownership
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Trends and Opportunities
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Trends and Opportunities
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Trends and Opportunities
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Trends and Opportunities
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Trends and Opportunities
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Ownership
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Trends and Opportunities
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Trends and Opportunities
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Trends and Opportunities
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Trends and Opportunities
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Ownership
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Trends and Opportunities
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Trends and Opportunities
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Trends and Opportunities
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Trends and Opportunities
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Trends and Opportunities
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Trends and Opportunities
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Trends and Opportunities
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Walgreen Co., (Walgreens Boots Alliance, Inc.)
  • 10.2. Walmart Inc.
  • 10.3. Rite Aid Corp.
  • 10.4. NextCare
  • 10.5. Bellin Health Systems
  • 10.6. Sutter Health
  • 10.7. The Kroger Co.
  • 10.8. CVS Health
  • 10.9. MedExpress (Optum)
  • 10.10. Concentra, Inc.